How will I benefit?

Understanding the results of miRview™ meso

miRview™ meso gives you answers
Your doctor will receive a report about 10 days after your tumor sample arrives at Rosetta Genomics’ labs. The report will show if your cancer is malignant pleural mesothelioma or something else. If your cancer is not malignant pleural mesothelioma, it may be another type of lung cancer. It could also be a completely different kind of cancer from another part of your body that has metastasized to the lung or pleura.

miRview™ meso is accurate
miRview™ meso offers a higher level of diagnostic accuracy than any other test available today1. The sensitivity and specificity of this test have been shown to be 100% and 94%, respectively1.

miRview™ meso can help you move forward
miRview™ meso helps your doctor figure out whether your cancer is mesothelioma or not. Based on the report and other information, you and your doctor can decide on the best way to move forward in your battle against cancer.

  1. . Data on file, Rosetta Genomics.